Official registry condition

Type 2 Diabetes Mellitus peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Type 2 Diabetes Mellitus. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

4 profiles.

Registry update years

2013–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 245 selected PubMed records and 20 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Type 2 Diabetes Mellitus unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT02737891

PeptideScanner retained ClinicalTrials.gov record NCT02737891 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.

PeptideScanner change date
November 16, 2026
Cited source date
May 14, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07112872

PeptideScanner retained ClinicalTrials.gov record NCT07112872 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

PeptideScanner change date
November 14, 2026
Cited source date
November 12, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07889648

PeptideScanner retained ClinicalTrials.gov record NCT07889648 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
November 14, 2026
Cited source date
October 22, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →